Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology
Shalini S. Rao, Larissa Lago, Irene Volitakis, Jay J. Shukla, Gawain McColl, David I. Finkelstein, Paul A. Adlard
Topics & Concepts
TauopathyDeferiproneNeuropathologyHippocampusGenetically modified mouseNeurologyChemistryNeuroscienceTau proteinAlzheimer's diseaseCognitive declineTransgenePharmacologyPsychologyPathologyNeurodegenerationInternal medicineMedicineDeferoxamineDiseaseDementiaBiochemistryGeneAlzheimer's disease research and treatmentsTrace Elements in HealthNeurological diseases and metabolism